AstraZeneca's cancer drug pipeline, already on a roll following promising clinical trial results, could get a further boost next week from a European green light for an experimental medicine against ovarian cancer.
Olaparib
Breaking News
- Telegram Russian Founder Says Messaging App to Cross 1 Billion User Mark Soon as It Continues to Remain a 'Neutral Platform'
- Google Confirms More Layoffs, Relocations as Part of Finance Team Restructuring Amid AI Shift
- UPDATE: Google Employees Arrested and Fired After Staging Protests Over Company's Project Nimbus Deal With Israel
Subscribe to VCpost newsletter
Most Popular
- China Hits 2 U.S. Defense Companies With Sanctions For Selling Military Weapons to Taiwan
- American Airlines Pilots Union Issues Urgent Safety Alert Over Maintenance Issues
- Social Security Benefits: 2025 COLA Predicted to Increase Amid Rising Inflation
- Trump Media’s First Auditor Quits After Just a Few Months on the Job: Report
- SSDI Payment April 2024: Who Will Receive Social Security Benefits Today?
- Convicted Fraudster Accused of Killing Wealthy Heiress Wife in Swimming Pool to Cash in on Over $4 Million Fortune
- Spirit Airlines Staff at Florida Airport Filmed Cursing a 'Karen' Passenger After Moaning About Her Flight
- Innocent Female Uber Driver, 61, Shot Dead by 81-Year-Old Ohio Man Who Was Targeted by Scammers
